GREEN THUMB INDS - stock earnings
R9U2.F Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 2.9 million EUR | 251.7 million EUR |
| 2023Q3 | 9.9 million EUR | 260.1 million EUR |
| 2023Q2 | 12.3 million EUR | 232.1 million EUR |
| 2023Q1 | 8.4 million EUR | 228.0 million EUR |
| 2022Q4 | -47.7 million EUR | 241.6 million EUR |
| 2022Q3 | 10.0 million EUR | 266.3 million EUR |
| 2022Q2 | 23.4 million EUR | 243.2 million EUR |
| 2022Q1 | 25.9 million EUR | 217.4 million EUR |
| 2021Q4 | 20.1 million EUR | 214.2 million EUR |
| 2021Q3 | 17.4 million EUR | 201.8 million EUR |
| 2021Q2 | 18.6 million EUR | 187.1 million EUR |
| 2021Q1 | 8.8 million EUR | 165.8 million EUR |
| 2020Q4 | 18.4 million EUR | 145.5 million EUR |
| 2020Q3 | 8.2 million EUR | 133.9 million EUR |
| 2020Q2 | -11.5 million EUR | 106.5 million EUR |
| 2018Q2 | 339780 EUR | 11.8 million EUR |
| 2018Q1 | -1.3 million EUR | 8.9 million EUR |
| 2017Q3 | -49985 EUR | ? EUR |
| 2017Q2 | -1.2 million EUR | 3.0 million EUR |
| 2017Q1 | 1.1 million EUR | 2.8 million EUR |
| 2016Q4 | -61898 EUR | ? EUR |
R9U2.F Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 32.8 million EUR | 954.0 million EUR |
| 2022 | 11.2 million EUR | 948.0 million EUR |
| 2021 | 66.3 million EUR | 785.7 million EUR |
| 2020 | 12.3 million EUR | 457.0 million EUR |
| 2019 | -52.8 million EUR | 193.2 million EUR |
| 2018 | -6.9 million EUR | 54.6 million EUR |
| 2017 | -194571 EUR | 13.8 million EUR |
| 2016 | -2.9 million EUR | 6.9 million EUR |
| 2015 | -1.2 million EUR | ? EUR |
| 2014 | -4.1 million EUR | ? EUR |
| 2013 | -553346 EUR | ? EUR |
R9U2.F
Price: €11.24
52 week price:
Earnings Per Share: 0.14 EUR
P/E Ratio: 126.70
Exchange: FRA
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1261
Market Capitalization: 3.2 billion